- Category
- Small (2020-21)
- Udyam number
- UDYAM-UK-06-0003877

Spectrum Formulation Private Limited
About Spectrum Formulation Private Limited
Data last updated:
Spectrum Formulation Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 May 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U74140MP2005PTC017577. Its GSTIN is 05AAJCS3565N1ZU (Uttarakhand).
The company has an authorised share capital of ₹1.2 Cr and a paid-up capital of ₹1.2 Cr. It was formerly known as Visharad Distibutor Private Limited. It is led by directors including Harsh Aggarwal and Shubham Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Indore, Madhya Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹42.18 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net loss of ₹26.58 Cr (net margin -63%) and EBITDA of -₹24.9 Cr (EBITDA margin -59%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 40% over five years.
The company has about 30 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Spectrum Formulation. As per MCA filings, the company has open charges of ₹9.42 Cr and satisfied charges of ₹7.62 Cr on record. Court records list 22 cases involving the company, including 7 filed by the company and 15 filed against it; 10 cases are pending.
Spectrum Formulation Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0003877). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Name history
Spectrum Formulation has undergone 3 name changes throughout its history. The company was previously known as Visharad Distibutor Private Limited, Spectrum Formulation Private Limited, and Visharad Formulation Private Limited. The current legal name is Spectrum Formulation Private Limited.
| Company Name | Status |
|---|---|
| Spectrum Formulation Private Limited | Current |
| Visharad Distibutor Private Limited | Previous |
| Visharad Formulation Private Limited | Previous |
Recognitions & Rankings of Spectrum Formulation
Contact details
Spectrum Formulation Private Limited's registered office is in Indore, Madhya Pradesh. Its website is 9997680999. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOffice No. 305 3rd Floor Satguru Parinay, 5Pu – 3 Scheme No 54 A.B. Road, Indore, Madhya Pradesh, India – 452010
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Spectrum Formulation Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Spectrum Formulation operates one associated brand: Spectrum Formulation. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing, supplying, and distributing pharmaceutical products in India. | spectrumformulation.com |
Business activity
The main business activity of Spectrum Formulation is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Spectrum Formulation Private Limited, buy the company report.
Financials of Spectrum Formulation Private Limited
FY 2025 filings availableSpectrum Formulation Private Limited reported revenue of ₹42.18 Cr (up 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 40% over five years, including 23% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹42.18 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹24.9 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹26.58 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -59% | ||||
| Net Profit Margin | -63% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Spectrum Formulation Private Limited, buy the company report.
Board of directors of Spectrum Formulation Private Limited
Spectrum Formulation has 3 current directors and 21 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harsh Aggarwal Also directs: Atlantis Lifesciences Private Limited | Director | 11 Nov 2022 | 4 Years 0 Months | Current |
| Shubham Gupta | Director | 03 Jan 2023 | 3 Years 10 Months | Current |
| Anurag Aggarwal | Director | 11 Nov 2022 | 4 Years 0 Months | Current |
Peer comparison
Spectrum Formulation Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Legency Remedies Private Limited | ₹42.77 Cr (FY 2025) | -11.0% | Baddi, Himachal Pradesh, India | |||
| Brussels Laboratories Pvt Ltd | ₹42.73 Cr (FY 2025) | 7.0% | Dist-Ahmedabad, Gujarat, India | |||
| La Chemico Pvt Ltd | ₹42.52 Cr (FY 2024) | 0.0% | Kolkata, West Bengal, India | |||
| Maya Biotech Private Limited | ₹42.5 Cr (FY 2024) | -3.0% | Chandigarh, India | |||
| Base Medico Private Limited | ₹42.21 Cr (FY 2025) | -12.0% | Vadodara, Gujarat, India | |||
| Spectrum Formulation Private Limitedthis company | ₹42.18 Cr (FY 2025) | -₹26.58 Cr | -63% | 23.0% | 30 | Indore, Madhya Pradesh, India |
| Supercure Biotech Private Limited | ₹42.03 Cr (FY 2024) | 6.0% | Delhi, India | |||
| International Ingredients & Excipients Private Limited | ₹41.96 Cr (FY 2025) | 58.0% | Chennai, Tamil Nadu, India | |||
| Samrudh Pharmacare Private Limited | ₹41.88 Cr (FY 2024) | -7.0% | Mumbai, Maharashtra, India | |||
| Aap Pharma Technologies India Private Limited | ₹41.83 Cr (FY 2024) | -13.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Spectrum Formulation Private Limited, buy the company report.
Auditor
Spectrum Formulation Private Limited is audited by R. Tayal & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R. Tayal & Associates | FY 2024 | 006969N |
Shareholding
The shareholding of Spectrum Formulation Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Spectrum Formulation Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Dec 2024 | 101048914 | Axis Bank Limited | ₹2.2 Cr | Open | |
| 15 May 2024 | 100926877 | Axis Bank Limited | ₹2.7 Cr | Open | |
| 28 May 2021 | 100449217 | Axis Bank Limited | ₹4.52 Cr | Open | |
| 28 May 2021 | 100449219 | Axis Bank Limited | ₹50 Lakh | Satisfied | |
| 28 May 2021 | 100449852 | Axis Bank Limited | ₹31.07 Lakh | Satisfied |
To see the full charge records of Spectrum Formulation Private Limited, buy the company report.
Total charge records: 11 View all charges
Legal cases
Spectrum Formulation Private Limited has 22 court cases on record: 7 filed by Spectrum Formulation, 15 filed against it. 10 cases are pending and 12 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 19 | 13 | 8 |
| High courts | 3 | 2 | 2 |
Cases on record (5 of 22)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Haridwar, Uttarakhand | Criminal case | Filed by the company against M/S Tenzer Life Care Pvt, Ltd | Pending |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Boehringer Ingelheim (India) Pvt. Ltd. and 1 other | Pending |
| District court, North, Delhi | Interim or miscellaneous application | Filed against the company by Itl Labs Pvt Ltd. | Disposed |
| District court, North, Delhi | Civil suit | Filed against the company by Itl Labs Pvt. Ltd | Disposed |
| District court, Pune, Maharashtra | Civil suit | Filed against the company | Pending |
To see the full case history of Spectrum Formulation Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Spectrum Formulation Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 442 overdue payments to 32 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 32)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| Radiant Printo Pack | |||
| Garud Industries |
To see the full MSME payment records of Spectrum Formulation Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Spectrum Formulation Private Limited has a workforce of 30 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 30 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 |
To see the full employee and EPFO history of Spectrum Formulation Private Limited, buy the company report.
GST
Spectrum Formulation has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAJCS3565N1ZU | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Spectrum Formulation Private Limited, buy the company report.
Recent activity
Spectrum Formulation Private Limited has 25 board changes on record since 2009: 4 appointments and 21 cessations. The latest: Aman Aggarwal ceased to be Additional Director on 29 Sep 2023.
39 earlier events are in the company report.
Frequently asked questions
Spectrum Formulation is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 May 2005 (21+ years old) and is registered under CIN U74140MP2005PTC017577.
Spectrum Formulation has 3 current directors:
- Harsh Aggarwal - Director
- Shubham Gupta - Director
- Anurag Aggarwal - Director
The latest financial statements of Spectrum Formulation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Spectrum Formulation is 05AAJCS3565N1ZU, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Spectrum Formulation is U74140MP2005PTC017577. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spectrum Formulation has 22 court cases on record: 7 filed by the company and 15 filed against it. 10 are pending. Most are in the district courts.
Spectrum Formulation was incorporated on 05 May 2005, making it 21+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Spectrum Formulation by revenue are Legency Remedies Private Limited, Brussels Laboratories Pvt Ltd, La Chemico Pvt Ltd, Maya Biotech Private Limited, Base Medico Private Limited and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Aman Aggarwal ceased to be Additional Director on 29 Sep 2023. Anurag Aggarwal ceased to be Additional Director on 29 Sep 2023. Harsh Aggarwal ceased to be Additional Director on 29 Sep 2023. Spectrum Formulation has 25 board changes on record in total.
Yes, Spectrum Formulation is registered as a small enterprise under Udyam registration (number: UDYAM-UK-06-0003877).
Spectrum Formulation has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 442 overdue payments to 32 micro and small suppliers. The latest return was filed on 30 Apr 2024.
The registered office of Spectrum Formulation is at Office No. 305 3rd Floor Satguru Parinay, 5Pu – 3 Scheme No 54 A.B. Road, Indore, Madhya Pradesh, India – 452010.

